Cardiovascular Medicine: New Drug Developments for Complex Cardiovascular Diseases and Cardiovascular Imaging

Abstract

Cardiovascular diseases (CVDs) remain the leading cause of morbidity and mortality worldwide, with complex pathophysiological mechanisms contributing to their progression. Traditional therapeutic approaches, while effective in many cases, are often insufficient for treating the more intricate and multifactorial forms of CVDs. In recent years, significant strides have been made in the development of novel drugs aimed at addressing these complex CV conditions. These new treatments are being designed to target specific molecular pathways, such as inflammation, oxidative stress, and endothelial dysfunction, which play key roles in diseases like atherosclerosis, heart failure, and arrhythmias. Additionally, emerging drug classes, including gene therapies and biologics, are offering promising new strategies for managing patients with advanced or refractory CVDs, paving the way for more personalized and effective interventions